Tezepelumab for chronic sinusitis with nasal polyps in Japan
Treatments studied
Part of Ear, nose & throat clinical trials.
This study looks at how well tezepelumab works for people with chronic sinusitis and nasal polyps. It tracks symptoms and quality of life in real-world settings in Japan. If you have this condition and are considering tezepelumab, this study may help doctors understand its benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with chronic sinusitis with nasal polyps for at least 12 months.
- You have moderate to severe symptoms, shown by a score of 30 or more on a standard sinusitis questionnaire (SNOT-22) taken within the last 4 weeks.
- You have been treated for your sinusitis according to Japanese guidelines for at least 30 days.
- Your doctor has decided that tezepelumab is right for you based on approved use.
- You are not pregnant, planning pregnancy, or breastfeeding, and you have not had other biologic treatments for asthma or sinusitis recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called tezepelumab to see if it can improve symptoms for people with chronic sinusitis and nasal polyps who also have severe asthma. It may help reduce inflammation and improve breathing and nasal symptoms.
This study tests whether tezepelumab, a new injectable medicine, can help reduce nasal polyps and improve symptoms like nasal congestion, loss of smell, and sleep problems. You would receive the study drug while continuing your current nasal steroid spray, and your doctors would track how your symptoms change.
This study tests whether combining mepolizumab (a biologic injection) with a quick in-office removal of nasal polyps improves symptoms better than usual care. It is for adults with chronic sinusitis and nasal polyps who qualify for biologic therapy.
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.